412 related articles for article (PubMed ID: 32891866)
1. Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.
Kompella UB; Hartman RR; Patil MA
Prog Retin Eye Res; 2021 May; 82():100901. PubMed ID: 32891866
[TBL] [Abstract][Full Text] [Related]
2. Sustained release ocular drug delivery systems for glaucoma therapy.
Al-Qaysi ZK; Beadham IG; Schwikkard SL; Bear JC; Al-Kinani AA; Alany RG
Expert Opin Drug Deliv; 2023; 20(7):905-919. PubMed ID: 37249548
[TBL] [Abstract][Full Text] [Related]
3. A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes.
Chan HH; Wong TT; Lamoureux E; Perera S
J Glaucoma; 2015 Sep; 24(7):485-92. PubMed ID: 25580892
[TBL] [Abstract][Full Text] [Related]
4. Sustained drug delivery for glaucoma: current data and future trends.
Aref AA
Curr Opin Ophthalmol; 2017 Mar; 28(2):169-174. PubMed ID: 27764023
[TBL] [Abstract][Full Text] [Related]
5. Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.
Chiang B; Kim YC; Doty AC; Grossniklaus HE; Schwendeman SP; Prausnitz MR
J Control Release; 2016 Apr; 228():48-57. PubMed ID: 26930266
[TBL] [Abstract][Full Text] [Related]
6. [Progression of drug delivery system for glaucoma].
Xu Y; Lyu L
Zhonghua Yan Ke Za Zhi; 2014 Dec; 50(12):946-51. PubMed ID: 25619186
[TBL] [Abstract][Full Text] [Related]
7. Intracameral sustained release bimatoprost implants (Durysta).
Sirinek PE; Lin MM
Semin Ophthalmol; 2022 Apr; 37(3):385-390. PubMed ID: 34586961
[TBL] [Abstract][Full Text] [Related]
8. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
PLoS One; 2014; 9(4):e95461. PubMed ID: 24788066
[TBL] [Abstract][Full Text] [Related]
9. Sustained drug delivery in glaucoma.
Knight OJ; Lawrence SD
Curr Opin Ophthalmol; 2014 Mar; 25(2):112-7. PubMed ID: 24463419
[TBL] [Abstract][Full Text] [Related]
10. Medical anti-glaucoma therapy: Beyond the drop.
Miller PE; Eaton JS
Vet Ophthalmol; 2021 Mar; 24 Suppl 1():2-15. PubMed ID: 33164328
[TBL] [Abstract][Full Text] [Related]
11. Sustained drug release by contact lenses for glaucoma treatment-a review.
Carvalho IM; Marques CS; Oliveira RS; Coelho PB; Costa PC; Ferreira DC
J Control Release; 2015 Mar; 202():76-82. PubMed ID: 25617723
[TBL] [Abstract][Full Text] [Related]
12. Advances in innovative delivery systems for antiglaucoma drugs.
Chen X; Shen T
Curr Opin Ophthalmol; 2023 Mar; 34(2):123-128. PubMed ID: 36730446
[TBL] [Abstract][Full Text] [Related]
13. Patient Acceptance of Sustained Glaucoma Treatment Strategies.
Varadaraj V; Kahook MY; Ramulu PY; Pitha IF
J Glaucoma; 2018 Apr; 27(4):328-335. PubMed ID: 29462013
[TBL] [Abstract][Full Text] [Related]
14. Patient attitudes toward novel glaucoma drug delivery approaches.
Wang BB; Lin MM; Nguyen T; Turalba AV
Digit J Ophthalmol; 2018; 24(2):16-23. PubMed ID: 30800009
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
16. Novel drug delivery systems for glaucoma.
Lavik E; Kuehn MH; Kwon YH
Eye (Lond); 2011 May; 25(5):578-86. PubMed ID: 21475311
[TBL] [Abstract][Full Text] [Related]
17. Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications.
Belamkar A; Harris A; Zukerman R; Siesky B; Oddone F; Verticchio Vercellin A; Ciulla TA
Ann Med; 2022 Dec; 54(1):343-358. PubMed ID: 35076329
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.
Lusthaus JA; Goldberg I
Expert Opin Emerg Drugs; 2016; 21(1):117-28. PubMed ID: 26854598
[TBL] [Abstract][Full Text] [Related]
19. A Survey on Patients' Opinions of Alternative Drug Delivery Systems for the Treatment of Glaucoma in South-South Nigeria.
Echieh CI; Mercieca K; Eze UA; Weber C; Akinyemi A; Ibanga AA; Echieh CP
Middle East Afr J Ophthalmol; 2022; 29(4):220-225. PubMed ID: 38162567
[TBL] [Abstract][Full Text] [Related]
20. Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SOA; Cronemberger S; Nogueira JC; Ferreira AJ; Faraco AAG
Int J Pharm; 2019 Oct; 570():118662. PubMed ID: 31491481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
